THE LANCET - Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

THE LANCET - Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

The LancetA safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the...
NEJM - Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

NEJM - Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

The New England Journal of MedicineVaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine...
ECDC - Risk Assessment: Risk related to spread of new SARS-CoV-2 variants of concern in the EU/EEA

ECDC - Risk Assessment: Risk related to spread of new SARS-CoV-2 variants of concern in the EU/EEA

European Centre for Disease Prevention and ControlViruses constantly change through mutation, and so the emergence of new variants is an expected occurrence and not in itself a cause for concern; SARS-CoV-2 is no exception. A diversification of...
DGS - Campanha de Vacinação contra a COVID-19

DGS - Campanha de Vacinação contra a COVID-19

Direção-Geral da Saúde

Norma dirigida a médicos, enfermeiros, farmacêuticos do Sistema de Saúde.

NEJM - Tocilizumab in Patients Hospitalized with Covid-19

NEJM - Tocilizumab in Patients Hospitalized with Covid-19

The New England Journal of MedicineThe efficacy of tocilizumab was tested in a randomized, controlled trial involving patients with Covid-19 who had fever, pulmonary infiltrates, or a need for supplemental oxygen. The treatment had no significant...
INFARMED - COVID-19 – Operacionalização da utilização dos Testes Rápidos de Antigénio (TRAg)

INFARMED - COVID-19 – Operacionalização da utilização dos Testes Rápidos de Antigénio (TRAg)

Autoridade Nacional do Medicamento e Produtos de SaúdeNo contexto da atual situação epidemiológica provocada pelo novo coronavírus SARS-CoV-2 e pela doença COVID-19, o Ministério da Saúde tem vindo a adotar e implementar medidas com vista à...
DGS - COVID-19: Acompanhantes e Visitas nas Unidades Hospitalares

DGS - COVID-19: Acompanhantes e Visitas nas Unidades Hospitalares

Orientação da Direção-Geral da SaúdeA Pandemia COVID-19 impôs um conjunto de medidas de caráter extraordinário nas unidades hospitalares do Serviço Nacional de Saúde (SNS), num esforço concertado para a redução das cadeias de transmissão...
WHO - Evidence to recommendations for COVID-19 vaccines: Evidence framework

WHO - Evidence to recommendations for COVID-19 vaccines: Evidence framework

World Health OrganizationAs market-authorized COVID-19 vaccines become available, specific recommendations for the use of these vaccines will need to be issued. This SAGE evidence framework is intended to offer guidance for considering data...
ECDC - Overview of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA and the UK

ECDC - Overview of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA and the UK

European Centre for Disease Prevention and ControlThis report provides an initial overview of the national COVID-19 vaccination strategies and vaccine deployment plans in the countries of the European Union and European Economic Area (EU/EEA) and...
NEJ - Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

NEJ - Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

The New England Journal of MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe and effective...
AMP - Cutaneous Manifestations Associated with COVID-19: A Narrative Review

AMP - Cutaneous Manifestations Associated with COVID-19: A Narrative Review

Acta Médica PortuguesaCOVID-19 is an infectious disease caused by the new coronavirus, SARS-CoV-2, that has spread rapidly throughout the world. This has resulted in an urgent need to obtain information regarding its pathogenesis, diagnosis and...
ECDC - Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA - Second update

ECDC - Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA - Second update

European Centre for Disease Prevention and ControlThis second update of the original document integrates the experience of maintaining safe and sufficient supply of substances of human origin (SoHO) gained in the course of the COVID-19 pandemic...
ECDC - Rapid Risk Assessment: Risk of COVID-19 transmission related to the end-of-year festive season

ECDC - Rapid Risk Assessment: Risk of COVID-19 transmission related to the end-of-year festive season

European Centre for Disease Prevention and ControlAfter a scale-up of non-pharmaceutical interventions implemented by several Member Sates starting from the end of October, a recent overall decreasing trend in the 14-day COVID-19 notification...
WHO - Draft landscape of COVID-19 candidate vaccines – 26 November 2020

WHO - Draft landscape of COVID-19 candidate vaccines – 26 November 2020

World Health OrganizationThese landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020 global of the novel coronavirus. Inclusion of any particular product or entity in...
NEJM - Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

NEJM - Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

The New England Journal of MedicineWorld Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs — remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a — in patients hospitalized with...
123468910Último
Eventos
«dezembro de 2023»
segterquaquisexsábdom
27282930123
45678910
11121314151617
18192021222324
25262728293031
1234567
Categorias

Categorias

Arquivo de Notícias

Arquivo